Citation: Wenhua Shao, Wei Zhang, Zhitong Chen, Tingting Zhou, Xiaoyi Zhao, Hongyi Liu, Chuangwei Chen, Xingyan Dong, Weijun Cao, Zongsheng Zhao, Fan Yang, Zixiang Zhu, Haixue Zheng. STING1 negatively regulates translation and replication of foot-and-mouth disease virus independently of interferon and is antagonized by the viral proteins 3C and 2B .VIROLOGICA SINICA, 2026, 41(2) : 355-370.  http://dx.doi.org/10.1016/j.virs.2026.04.007

STING1 negatively regulates translation and replication of foot-and-mouth disease virus independently of interferon and is antagonized by the viral proteins 3C and 2B

  • Foot-and-mouth disease virus (FMDV), a highly contagious picornavirus, employs multifaceted strategies to evade host innate immunity, with viral proteins 3C protease (3Cpro) and 2B serving as key immune antagonists. The stimulator of interferon genes 1 (STING1) is a critical innate immune adaptor; however, its role and regulatory mechanisms during FMDV infection remain incompletely understood. Here, we report that STING1 inhibits FMDV replication through an interferon (IFN)-independent mechanism, while FMDV counteracts this antiviral effect by degrading STING1 via 3Cpro and 2B. Mechanistically, FMDV 3Cpro mediates STING1 degradation in a protease activity-dependent manner; this STING1-degrading activity is conserved among 3Cpro proteins of poliovirus, enterovirus 71, and coxsackievirus, but not senecavirus A. In contrast, FMDV 2B suppresses STING1 expression at the mRNA level, and neither proteasomal, lysosomal, nor caspase pathways are involved in 3Cpro/2B-mediated STING1 downregulation. Furthermore, the STING1 stabilizer SB24011 enhances endogenous STING1 expression, dose-dependently inhibits FMDV replication by targeting viral internal ribosome entry site (IRES)-mediated translation, and exhibits broad-spectrum antiviral activity against multiple picornaviruses. In vivo, SB24011 treatment alleviates virus-induced histopathological lesions. Collectively, our findings reveal a novel IFN-independent antiviral role of STING1 against FMDV, identify 3Cpro and 2B as FMDV-encoded STING1 antagonists, and highlight the potential of SB24011 as a broad-spectrum anti-picornavirus therapeutic agent.

  • 加载中
  • 10.1016j.virs.2026.04.007-ESM.docx
    1. Amurri, L., Horvat, B., Iampietro, M., 2023. Interplay between RNA viruses and cGAS/STING axis in innate immunity. Frontiers in cellular and infection microbiology 13, 1172739.

    2. Barral, P.M., Sarkar, D., Fisher, P.B., Racaniello, V.R., 2009. RIG-I is cleaved during picornavirus infection. Virology 391, 171-176.

    3. Belsham, G.J., 2005. Translation and replication of FMDV RNA. Curr Top Microbiol Immunol 288, 43-70.

    4. Birtley, J.R., Knox, S.R., Jaulent, A.M., Brick, P., Leatherbarrow, R.J., Curry, S., 2005. Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism and cleavage specificity. The Journal of biological chemistry 280, 11520-11527.

    5. Cho, W., Won, S., Choi, Y., Yi, S., Park, J.B., Park, J.G., Kim, C.E., Narayana, C., Kim, J.H., Yim, J., Choi, Y.I., Lee, D.S., Park, S.B., 2023. Targeted Protein Upregulation of STING for Boosting the Efficacy of Immunotherapy. Angewandte Chemie 62, e202300978.

    6. Cui, Z., Shen, K., Xu, M., Yao, Y., Shao, H., Qin, A., Qian, K., 2025. Avian leukosis virus p15 interacts with interferon regulatory factor 7 to antagonize the cGAS-STING signaling pathway and promote viral replication. Journal of virology 99, e0038025.

    7. Denver, S., Alban, L., Boklund, A., Houe, H., Mortensen, S., Rattenborg, E., Tamstorf, T.V., Zobbe, H., Christensen, T., 2016. The costs of preventive activities for exotic contagious diseases-A Danish case study of foot and mouth disease and swine fever. Preventive veterinary medicine 131, 111-120.

    8. Du, Y., Bi, J., Liu, J., Liu, X., Wu, X., Jiang, P., Yoo, D., Zhang, Y., Wu, J., Wan, R., Zhao, X., Guo, L., Sun, W., Cong, X., Chen, L., Wang, J., 2014. 3Cpro of foot-and-mouth disease virus antagonizes the interferon signaling pathway by blocking STAT1/STAT2 nuclear translocation. Journal of virology 88, 4908-4920.

    9. Falk, M.M., Grigera, P.R., Bergmann, I.E., Zibert, A., Multhaup, G., Beck, E., 1990. Foot-and-mouth disease virus protease 3C induces specific proteolytic cleavage of host cell histone H3. Journal of virology 64, 748-756.

    10. Forss, S., Strebel, K., Beck, E., Schaller, H., 1984. Nucleotide sequence and genome organization of foot-and-mouth disease virus. Nucleic acids research 12, 6587-6601.

    11. Fu, Y., Wang, C., Sun, W., Kong, H., Liang, W., Shi, T., Li, Q., Jia, M., Zhao, W., Song, H., 2025. MINT3 promotes STING activation and facilitates antiviral immune responses. Cellular signalling 132, 111825.

    12. Gamarnik, A.V., Andino, R., 1998. Switch from translation to RNA replication in a positive-stranded RNA virus. Genes & development 12, 2293-2304.

    13. Grubman, M.J., Baxt, B., 2004. Foot-and-mouth disease. Clinical microbiology reviews 17, 465-493.

    14. Habjan, M., Penski, N., Spiegel, M., Weber, F., 2008. T7 RNA polymerase-dependent and -independent systems for cDNA-based rescue of Rift Valley fever virus. The Journal of general virology 89, 2157-2166.

    15. Ishikawa, H., Ma, Z., Barber, G.N., 2009. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity. Nature 461, 788-792.

    16. Ji, W., Zhang, Y., Zhang, L., Liu, Q., Niu, S., Feng, Y., Chen, F., Liu, X., Li, X., 2025. VAPB is a negative regulator of STING-mediated innate immune signaling. Science advances 11, eaea3996.

    17. Jiao, P., Fan, W., Ma, X., Lin, R., Zhao, Y., Li, Y., Zhang, H., Jia, X., Bi, Y., Feng, X., Li, M., Liu, W., Zhang, K., Sun, L., 2023. SARS-CoV-2 nonstructural protein 6 triggers endoplasmic reticulum stress-induced autophagy to degrade STING1. Autophagy 19, 3113-3131.

    18. Li, C., Zhu, Z., Du, X., Cao, W., Yang, F., Zhang, X., Feng, H., Li, D., Zhang, K., Liu, X., Zheng, H., 2017. Foot-and-mouth disease virus induces lysosomal degradation of host protein kinase PKR by 3C proteinase to facilitate virus replication. Virology 509, 222-231.

    19. Li, D., Lei, C., Xu, Z., Yang, F., Liu, H., Zhu, Z., Li, S., Liu, X., Shu, H., Zheng, H., 2016a. Foot-and-mouth disease virus non-structural protein 3A inhibits the interferon-beta signaling pathway. Scientific reports 6, 21888.

    20. Li, D., Wei, J., Yang, F., Liu, H.N., Zhu, Z.X., Cao, W.J., Li, S., Liu, X.T., Zheng, H.X., Shu, H.B., 2016b. Foot-and-mouth disease virus structural protein VP3 degrades Janus kinase 1 to inhibit IFN-gamma signal transduction pathways. Cell cycle 15, 850-860.

    21. Li, D., Yang, W., Yang, F., Liu, H., Zhu, Z., Lian, K., Lei, C., Li, S., Liu, X., Zheng, H., Shu, H., 2016c. The VP3 structural protein of foot-and-mouth disease virus inhibits the IFN-beta signaling pathway. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 30, 1757-1766.

    22. Li, M., Xin, T., Gao, X., Wu, J., Wang, X., Fang, L., Sui, X., Zhu, H., Cui, S., Guo, X., 2018. Foot-and-mouth disease virus non-structural protein 2B negatively regulates the RLR-mediated IFN-beta induction. Biochemical and biophysical research communications 504, 238-244.

    23. Li, W., Ross-Smith, N., Proud, C.G., Belsham, G.J., 2001. Cleavage of translation initiation factor 4AI (eIF4AI) but not eIF4AII by foot-and-mouth disease virus 3C protease: identification of the eIF4AI cleavage site. FEBS letters 507, 1-5.

    24. Kim, H., Kim, A.Y., Choi, J., Park, S.Y., Park, S.H., Kim, J.S., Lee, S.I., Park, J.H., Park, C.K., Ko, Y.J., 2021. Foot-and-Mouth Disease Virus Evades Innate Immune Response by 3C-Targeting of MDA5. Cells 10.

    25. Li, Y., Chen, W., Zhang, X., Zhou, J., Hu, Y., Zhou, Y., Lan, T., Huang, H., Xie, L., Qin, Y., Zhou, L., Sun, W., Lu, H., 2025a. STING agonist diABZI confers protection against swine acute diarrhea syndrome coronavirus in neonatal mice by activating antiviral immunity. Journal of virology, e0170325.

    26. Li, Y., Liu, Y., Dai, Y., Niu, J., Li, G., Yu, X., Wan, C., Fang, R., Ye, C., 2025b. RACK1 Associates With STING to Promote Type I Interferon Activation and Inhibit Pseudorabies Virus Infection. Transboundary and emerging diseases 2025, 9584967.

    27. Liu, B., Carlson, R.J., Pires, I.S., Gentili, M., Feng, E., Hellier, Q., Schwartz, M.A., Blainey, P.C., Irvine, D.J., Hacohen, N., 2023a. Human STING is a proton channel. Science 381, 508-514.

    28. Liu, H., Zhu, Z., Xue, Q., Yang, F., Cao, W., Zhang, K., Liu, X., Zheng, H., 2019. Foot-and-Mouth Disease Virus Antagonizes NOD2-Mediated Antiviral Effects by Inhibiting NOD2 Protein Expression. Journal of virology 93.

    29. Liu, H., Zhu, Z., Xue, Q., Yang, F., Li, Z., Xue, Z., Cao, W., He, J., Guo, J., Liu, X., Shaw, A.E., King, D.P., Zheng, H., 2023b. Innate sensing of picornavirus infection involves cGAS-STING-mediated antiviral responses triggered by mitochondrial DNA release. PLoS pathogens 19, e1011132.

    30. Moffat, K., Howell, G., Knox, C., Belsham, G.J., Monaghan, P., Ryan, M.D., Wileman, T., 2005. Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport. Journal of virology 79, 4382-4395.

    31. Nayak, A., Goodfellow, I.G., Woolaway, K.E., Birtley, J., Curry, S., Belsham, G.J., 2006. Role of RNA structure and RNA binding activity of foot-and-mouth disease virus 3C protein in VPg uridylylation and virus replication. Journal of virology 80, 9865-9875.

    32. Nouri, H.R., Schaunaman, N., Kraft, M., Numata, M., Vercelli, D., Chu, H.W., 2025. Tollip deficiency enhances mitophagy and reduces STING activation in influenza A virus-infected mice. Journal of immunology 214, 1741-1753.

    33. Peng, T., Yang, F., Yang, F., Cao, W., Zheng, H., Zhu, Z., 2023. Structural diversity and biological role of the 5' untranslated regions of picornavirus. RNA biology 20, 548-562.

    34. Quintana, V., Caillava, J., Byk, L.A., Mondotte, J.A., Battini, L., Tarte, P., Samsa, M.M., Filomatori, C.V., Alvarez, D.E., 2025. Improvement in the potency of a N(1)-methylpseudouridine-modified self-amplifying RNA through mutations in the RNA-dependent RNA polymerase. The Journal of biological chemistry 301, 110487.

    35. Rodriguez Pulido, M., Saiz, M., 2017. Molecular Mechanisms of Foot-and-Mouth Disease Virus Targeting the Host Antiviral Response. Frontiers in cellular and infection microbiology 7, 252.

    36. Sui, C., Jiang, D., Wu, X., Liu, S., Li, F., Pan, L., Cong, X., Li, J., Yoo, D., Rock, D.L., Miller, L.C., Lee, C., Du, Y., Qi, J., 2021. Inhibition of Antiviral Innate Immunity by Foot-and-Mouth Disease Virus L(pro) through Interaction with the N-Terminal Domain of Swine RNase L. J Virol 95, e0036121.

    37. Sun, W., Li, Y., Chen, L., Chen, H., You, F., Zhou, X., Zhou, Y., Zhai, Z., Chen, D., Jiang, Z., 2009. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization. Proceedings of the National Academy of Sciences of the United States of America 106, 8653-8658.

    38. Tsuchida, T., Zou, J., Saitoh, T., Kumar, H., Abe, T., Matsuura, Y., Kawai, T., Akira, S., 2010. The ubiquitin ligase TRIM56 regulates innate immune responses to intracellular double-stranded DNA. Immunity 33, 765-776.

    39. Wang, A., Peng, Q., Fan, H., Ji, W., Lou, J., Zhou, X., Ren, Y., 2025a. Herpes simplex virus 1 encodes a STING antagonist that can be therapeutically targeted. Cell reports. Medicine 6, 102051.

    40. Wang, C., Feng, H., Zhang, X., Li, K., Yang, F., Cao, W., Liu, H., Gao, L., Xue, Z., Liu, X., Zhu, Z., Zheng, H., 2021. Porcine Picornavirus 3C Protease Degrades PRDX6 to Impair PRDX6-mediated Antiviral Function. Virol Sin 36, 948-957.

    41. Wang, D., Fang, L., Li, K., Zhong, H., Fan, J., Ouyang, C., Zhang, H., Duan, E., Luo, R., Zhang, Z., Liu, X., Chen, H., Xiao, S., 2012. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling. Journal of virology 86, 9311-9322.

    42. Wang, J., Liu, K., Zhang, H., Cao, W., Yan, Y., Wu, C., Wang, X., Yang, X., Liu, X., 2025b. Pseudorabies virus EP0 protein targets cGAS and STING for degradation through autophagy. Veterinary microbiology 311, 110766.

    43. Wang, X., Huang, Z., Xing, L., Shang, L., Jiang, J., Deng, C., Yu, W., Peng, L., Yang, H., Zheng, X., Liu, X., Yang, H., Chen, Y., Li, Y., Liu, J., Xie, X., Xu, W., Xia, X., Liu, Z., Liu, W., Jiang, S., Zeng, Y., Lu, L., Wang, J., 2025c. STING agonist-based ER-targeting molecules boost antigen cross-presentation. Nature 641, 202-210.

    44. Wang, X.T., Zhu, X., Lian, Z.H., Liu, Q., Yan, H.H., Qiu, Y., Ge, X.Y., 2025d. AUP1 and UBE2G2 complex targets STING signaling and regulates virus-induced innate immunity. mBio 16, e0060225.

    45. Wang, Y., Wu, S., Li, X., Qiao, L., Wang, H., Yang, G., Yan, H., Wang, K., Jiang, J.D., Li, Y., 2025e. Antiviral and immune modulatory activities of STING agonists in a mouse model of persistent hepatitis B virus infection. PLoS pathogens 21, e1013709.

    46. Weerawardhana, A., Uddin, M.B., Choi, J.H., Pathinayake, P., Shin, S.H., Chathuranga, K., Park, J.H., Lee, J.S., 2022. Foot-and-mouth disease virus non-structural protein 2B downregulates the RLR signaling pathway via degradation of RIG-I and MDA5. Frontiers in immunology 13, 1020262.

    47. Welsch, C., Haselow, K., Gouttenoire, J., Schneider, M., Morikawa, K., Martinez, Y., Susser, S., Sarrazin, C., Zeuzem, S., Antes, I., Moradpour, D., Lange, C.M., 2015. Hepatitis C virus variants resistant to macrocyclic NS3-4A inhibitors subvert IFN-beta induction by efficient MAVS cleavage. Journal of hepatology 62, 779-784.

    48. Wu, J., Dobbs, N., Yang, K., Yan, N., 2020. Interferon-Independent Activities of Mammalian STING Mediate Antiviral Response and Tumor Immune Evasion. Immunity 53, 115-126 e115.

    49. Wu, X., Chen, L., Sui, C., Hu, Y., Jiang, D., Yang, F., Miller, L.C., Li, J., Cong, X., Hrabchenko, N., Lee, C., Du, Y., Qi, J., 2023. 3C(pro) of FMDV inhibits type II interferon-stimulated JAK-STAT signaling pathway by blocking STAT1 nuclear translocation. Virol Sin 38, 387-397.

    50. Xie, S., Yan, J., Jiang, B., Liu, J., Song, J., 2025. Immune evasion strategies of Seneca Valley virus: mechanisms of host innate immune suppression. Agriculture Communications 3, 100100.

    51. Xu, L., Zhang, H., Qiu, Z., Wang, S., Wang, C., Cheng, H., Wan, Q., Pan, M., 2025. SESN1 negatively regulates STING1 to maintain innate immune homeostasis. Autophagy 21, 1245-1262.

    52. Xue, Q., Ma, K., Yang, F., Liu, H., Cao, W., Liu, P., Zhu, Z., Zheng, H., 2024. Foot-and-mouth disease virus 2B protein antagonizes STING-induced antiviral activity by targeting YTHDF2. FASEB journal : official publication of the Federation of American Societies for Experimental Biology 38, e70224.

    53. Yang, X., Lv, L., Zhang, Y., Zhang, Z., Zeng, S., Zhang, X., Wang, Q., Dorf, M., Li, S., Fu, B., 2025. ATP2A2 regulates STING1/MITA-driven signal transduction including selective autophagy. Autophagy 21, 2230-2245.

    54. Zhang, D., Liu, Y., Zhu, Y., Zhang, Q., Guan, H., Liu, S., Chen, S., Mei, C., Chen, C., Liao, Z., Xi, Y., Ouyang, S., Feng, X.H., Liang, T., Shen, L., Xu, P., 2022. A non-canonical cGAS-STING-PERK pathway facilitates the translational program critical for senescence and organ fibrosis. Nature cell biology 24, 766-782.

    55. Zhang, P., Rashidi, A., Zhao, J., Silvers, C., Wang, H., Castro, B., Ellingwood, A., Han, Y., Lopez-Rosas, A., Zannikou, M., Dmello, C., Levine, R., Xiao, T., Cordero, A., Sonabend, A.M., Balyasnikova, I.V., Lee-Chang, C., Miska, J., Lesniak, M.S., 2023. STING agonist-loaded, CD47/PD-L1-targeting nanoparticles potentiate antitumor immunity and radiotherapy for glioblastoma. Nature communications 14, 1610.

    56. Zhang, W., Li, W., Yang, Y., Cao, W., Shao, W., Huang, M., Wang, J., Chen, Z., Cai, J., Liu, H., Zhao, X., Dong, X., Zhou, T., Tian, H., Zhu, Z., Yang, F., Zheng, H., 2025. RING finger protein 5 is a key anti-FMDV host factor through inhibition of virion assembly. PLoS pathogens 21, e1012848.

    57. Zhang, W., Lian, K., Yang, F., Yang, Y., Zhu, Z., Zhu, Z., Cao, W., Mao, R., Jin, Y., He, J., Guo, J., Liu, X., Zheng, H., 2015. Establishment and evaluation of a murine alphanubeta3-integrin-expressing cell line with increased susceptibility to Foot-and-mouth disease virus. Journal of veterinary science 16, 265-272.

    58. Zhang, X., Yang, F., Li, K., Cao, W., Ru, Y., Chen, S., Li, S., Liu, X., Zhu, Z., Zheng, H., 2021. The Insufficient Activation of RIG-I-Like Signaling Pathway Contributes to Highly Efficient Replication of Porcine Picornaviruses in IBRS-2 Cells. Molecular & cellular proteomics : MCP 20, 100147.

    59. Zheng, Z., Zhao, M., Shan, H., Fang, D., Jin, Z., Tang, J., Liu, Z., Hong, L., Liu, P., Li, M., 2023. Noncanonical autophagy is a new strategy to inhibit HSV-1 through STING1 activation. Autophagy 19, 3096-3112.

    60. Zhi, X., Zhang, Y., Sun, S., Zhang, Z., Dong, H., Luo, X., Wei, Y., Lu, Z., Dou, Y., Wu, R., Jiang, Z., Weng, C., Seong Seo, H., Guo, H., 2020. NLRP3 inflammasome activation by Foot-and-mouth disease virus infection mainly induced by viral RNA and non-structural protein 2B. RNA biology 17, 335-349.

    61. Zhong, B., Yang, Y., Li, S., Wang, Y.Y., Li, Y., Diao, F., Lei, C., He, X., Zhang, L., Tien, P., Shu, H.B., 2008. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. Immunity 29, 538-550.

    62. Zhu, Z., Li, C., Du, X., Wang, G., Cao, W., Yang, F., Feng, H., Zhang, X., Shi, Z., Liu, H., Tian, H., Li, D., Zhang, K., Liu, X., Zheng, H., 2017. Foot-and-mouth disease virus infection inhibits LGP2 protein expression to exaggerate inflammatory response and promote viral replication. Cell death & disease 8, e2747.

    63. Zhu, Z., Wang, G., Yang, F., Cao, W., Mao, R., Du, X., Zhang, X., Li, C., Li, D., Zhang, K., Shu, H., Liu, X., Zheng, H., 2016. Foot-and-Mouth Disease Virus Viroporin 2B Antagonizes RIG-I-Mediated Antiviral Effects by Inhibition of Its Protein Expression. Journal of virology 90, 11106-11121.

    64. Zunszain, P.A., Knox, S.R., Sweeney, T.R., Yang, J., Roque-Rosell, N., Belsham, G.J., Leatherbarrow, R.J., Curry, S., 2010. Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate. Journal of molecular biology 395, 375-389.

  • 加载中

Figures(1)

Article Metrics

Article views(1995) PDF downloads(6) Cited by()

Related
Proportional views

    STING1 negatively regulates translation and replication of foot-and-mouth disease virus independently of interferon and is antagonized by the viral proteins 3C and 2B

      Corresponding author: Wei Zhang, zhangwei09@caas.cn
      Corresponding author: Zongsheng Zhao, zhaozongsh@sohu.com
      Corresponding author: Fan Yang, yangfan02@caas.cn
      Corresponding author: Zixiang Zhu, zhuzixiang@caas.cn
    • a. College of Animal Science and Technology, Shihezi University, Shihezi 832001, China;
    • b. State Key Laboratory of Animal Disease Control and Prevention, College of Veterinary Medicine, Lanzhou University, Lanzhou Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Lanzhou 730000, China

    Abstract: Foot-and-mouth disease virus (FMDV), a highly contagious picornavirus, employs multifaceted strategies to evade host innate immunity, with viral proteins 3C protease (3Cpro) and 2B serving as key immune antagonists. The stimulator of interferon genes 1 (STING1) is a critical innate immune adaptor; however, its role and regulatory mechanisms during FMDV infection remain incompletely understood. Here, we report that STING1 inhibits FMDV replication through an interferon (IFN)-independent mechanism, while FMDV counteracts this antiviral effect by degrading STING1 via 3Cpro and 2B. Mechanistically, FMDV 3Cpro mediates STING1 degradation in a protease activity-dependent manner; this STING1-degrading activity is conserved among 3Cpro proteins of poliovirus, enterovirus 71, and coxsackievirus, but not senecavirus A. In contrast, FMDV 2B suppresses STING1 expression at the mRNA level, and neither proteasomal, lysosomal, nor caspase pathways are involved in 3Cpro/2B-mediated STING1 downregulation. Furthermore, the STING1 stabilizer SB24011 enhances endogenous STING1 expression, dose-dependently inhibits FMDV replication by targeting viral internal ribosome entry site (IRES)-mediated translation, and exhibits broad-spectrum antiviral activity against multiple picornaviruses. In vivo, SB24011 treatment alleviates virus-induced histopathological lesions. Collectively, our findings reveal a novel IFN-independent antiviral role of STING1 against FMDV, identify 3Cpro and 2B as FMDV-encoded STING1 antagonists, and highlight the potential of SB24011 as a broad-spectrum anti-picornavirus therapeutic agent.

    Figure (1)  Reference (64) Relative (20)

    目录

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return